XML 83 R58.htm IDEA: XBRL DOCUMENT v2.4.0.8
Commitments and Contingencies (Details) (USD $)
3 Months Ended 12 Months Ended
Jun. 30, 2013
Dec. 31, 2013
Dec. 31, 2013
Td Vaccine Products [Member]
Dec. 31, 2013
H Lundbeck AS [Member]
Product
Dec. 22, 2011
H Lundbeck AS [Member]
Strategic Business Agreement [Abstract]          
Contingent future milestone payments - 2014   $ 4,524,000      
Contingent future milestone payments - 2015   598,000      
Contingent future milestone payments - 2016   200,000      
Contingent future milestone payments - Total   5,322,000      
Business Acquisition [Line Items]          
Number of NDAs off patent, branded injectable products       3  
Cash paid at closing         45,000,000
Additional consideration owed       15,000,000  
Cost of capital on additional consideration to be paid (in hundredths)       9.00%  
Discounted value of liability related to additional consideration in a business acquisition         11,600,000
Liability related to additional consideration in a business acquisition including accrual of non-cash interest expense       14,700,000  
Number of products related to minimum annual purchase obligations       2  
Number of products acquired       3  
Supply purchase agreement commitment       13,300,000  
Fair value of long-term liability on a purchase obligation         2,500,000
Number of years related to warranty expiration   10 years      
Reduction in cost of sales due to warranty reserve reversal 1,300,000        
Initial contract term of distribution agreement     2 years    
Commitment to acquire inventory under distribution agreement     9,200,000    
Minimum notice period for non-renewal of MBL Settlement Agreement     6 months    
Write-off of contract liability   $ 1,300,000